Laura Melado Vidales: High-Specific AMH Assays Refine Assessment of Low Ovarian Reserve
Laura Melado Vidales, Medical Director ART Fertility Clinics Abu Dhabi at ART Fertility Clinics, shared a post on LinkedIn about a paper published in Frontiers:
“Excited to share that our new paper is out in Frontiers in Endocrinology!
‘How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-Müllerian hormone with antral follicle count.’
Read here.
We show that combining high-specific AMH assays with antral follicle count (AFC) improves the prediction of ovarian response in women with low ovarian reserve, supporting more personalized fertility care.
Grateful to my co-authors and colleagues for this great collaboration!”
Title: How to enhance prediction of clinical outcomes in poor responders: integrating high-specific assays for anti-mullerian hormone with antral follicle count
Authors: Laura Melado, Ajay Kumar, Bhanu Kalra, Erkan Kalafat, Barbara Lawrenz, Human Fatemi
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic